Sunmax Biotechnology Company Description
Sunmax Biotechnology Co., Ltd., a biomedical company, develops, manufactures, and markets collagen-based medical devices in Taiwan and Mainland China.
The company offers dermal fillers, including Sunmax FACIALGAIN collagen implant with lidocaine, Sunmax collagen implant I-Plus, Sumax collagen implant I, Sunmax FACIALGAIN collagen implant 1-Plus with lidocaine for the correction of facial defects, such as the fill up of wrinkles; and Porcogen, a sterile purified collagen solution for medical device, tissue engineering, and research purposes.
It also provides Sunmax collagen dental bone graft, Sunmax collagen dental membrane, and Sunmax dental bone graft granules, which are used in the augmentation or reconstructive treatment of the alveolar ridge.
In addition, the company offers Sunmax collagen bone graft matrix that provides a bone void filler that is resorbed and replaced with bone during the healing process; and skincare products comprising Sunmax 12 jiao didi spray, Sunmax 11 collagen moisturizing cream, and Sunmax collagen skincare that are used as aftercare of dermal filler treatment.
Sunmax Biotechnology Co., Ltd. was founded in 2001 and is headquartered in Tainan City, Taiwan.
Country | Taiwan |
Founded | 2001 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Ming Yi Lin |
Contact Details
Address: No. 10, Lane 31, Huandong Road Tainan City, 744 Taiwan | |
Phone | 886 6 505 3288 |
Website | sunmaxbiotech.com |
Stock Details
Ticker Symbol | 4728 |
Exchange | Taipei Exchange |
Fiscal Year | January - December |
Reporting Currency | TWD |
ISIN Number | TW0004728001 |
SIC Code | 2836 |
Key Executives
Name | Position |
---|---|
Ming Yi Lin | Manager |